Medical Device News Magazine

Spark Biomedical Taps AcuityMD to “Turbo-Charge” Efforts to Build New Market of Non-Invasive Therapeutics for Opioid Use Disorder

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • Spark Biomedical, a leading developer of wearable neurostimulation solutions, has partnered with AcuityMD, a commercial platform provider for medical technology companies, to accelerate Spark Biomedical’s expansion of a new and growing market for treatment of withdrawal associated with opioid use disorder.

Spark Biomedical, a leading developer of wearable neurostimulation solutions, has partnered with AcuityMD, a commercial platform provider for medical technology companies, to accelerate Spark Biomedical’s expansion of a new and growing market for treatment of withdrawal associated with opioid use disorder. Spark Biomedical’s FDA-approved Sparrow Therapy System is a drug-free tool that includes a patient controller and earpiece that send mild electrical impulses to the brain to help alleviate opiate withdrawal symptoms.

AcuityMD’s data-driven targeting platform supports Spark Biomedical’s ambitious goals of providing a safe pathway to life-restoring sobriety to the millions of people suffering from opioid addiction.

Overdose deaths involving prescription opioids increased more than 20% in 2020, widely attributed to pandemic-related mental health issues. In addition, growth in drug use has caused overdose deaths from synthetic opioids such as fentanyl, which increased by more than 50% from 2019 to 2020. Spark Biomedical novel therapeutic aids detoxification with 84% of participants experiencing mild to no withdrawal symptoms within 60 minutes of therapy. And, after two days of treatment, 100% of patients sustained a clinically meaningful reduction in opioid withdrawal.

“In the treatment of substance abuse disorders, we need to address the entire continuum of care,” said Dan Wagner, Chief Commercial Officer for Spark Biomedical. “It starts with education and de-stigmatization, and continues to detoxification, therapy, and a lifetime of support. It is difficult to identify optimal channels for product adoption, so we are taking every effort to understand the treating physicians, therapists, rehab facilities, caregivers, and patients. AcuityMD’s targeting platform is the linchpin to this process, helping expand access and bring our device to more patients faster.”

The Sparrow Therapy System is already in use in more than two dozen rehabilitation facilities nationwide, but the company aspires to increase market penetration of its next-generation system with AcuityMD. Thousands of sales and marketing professionals from pre-commercial to enterprise medical device companies use AcuityMD’s commercial platform to improve targeting and planning, increase productivity, and accelerate patient access to innovative medical technology. AcuityMD’s most active users typically achieve a 25% increase in sales.

“Spark Biomedical is working tirelessly to help end the opioid epidemic in America, so we consider it very high praise to be chosen as their partner,” said Michael Monovoukas, CEO and co-founder of AcuityMD, which recently raised $31 million in Series A funding. “Since 2021, medical device companies have identified more than 40,000 new opportunities using our software, each one an opportunity to bring life-changing medical technology to more patients – the ultimate goal for both us and Spark Biomedical.”

“AcuityMD’s data-driven, intuitive platform is helping us turbo-charge our go-to-market efforts, so we can strategically get the right device in front of the right people at the right time,” concluded Spark Biomedical’s Dan Wagner. “And, given this country’s overdose rates, there’s no time to waste.”

Learn more about how Spark Biomedical is changing how substance abuse is treated with AcuityMD at the AdvaMed MedTech Conference 2022 (October 24-26, 2022) at the Boston Convention & Exhibition Center.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.